US Broker Ratings

Certara, Inc. (CERT) Stock Analysis: Exploring an 86.93% Potential Upside in Healthcare Tech

For investors with an eye on the healthcare technology sector, Certara, Inc. (NASDAQ: CERT) presents an intriguing proposition. With a current market cap of $1.05 billion, this U.S.-based company is..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: 42% Upside Potential Ignites Investor Interest

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of investors with its promising growth prospects and a compelling potential upside. As a prominent player in the healthcare sector, specifically..

Apellis Pharmaceuticals (APLS) Stock Analysis: 56% Potential Upside Beckons Investors

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a noteworthy player in the biotechnology sector, with a focus on developing and commercializing innovative therapeutic compounds. Headquartered in Waltham, Massachusetts, Apellis operates within..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenging Waters in the Healthcare Sector

BGM Group Ltd. (BGM), a player in the healthcare sector specializing in active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives, has recently caught the attention of investors. Based in..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Evaluating a 219.73% Potential Upside in Biotech Innovation

Viking Therapeutics, Inc. (NASDAQ: VKTX) has garnered significant attention in the biotech sector, thanks to its robust pipeline of innovative drug candidates and an impressive potential upside of 219.73%, as..

Investor Outlook: Galapagos NV (GLPG) Faces Challenges Amidst Potential Downside

Galapagos NV (NASDAQ: GLPG), a biotechnology firm hailing from Belgium, is capturing investor attention not only for its innovative medical advancements but also for the financial challenges it currently faces...

PROCEPT BioRobotics (PRCT) Stock Analysis: A 83% Upside Potential Awaits in Revolutionary Medical Devices

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector with its innovative approach to urologic surgery. Specializing in surgical robotics, this San Jose-based company is gaining attention..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Revenue Growth Soars as Analysts Eye 24.65% Upside

Alignment Healthcare, Inc. (ALHC), a key player in the healthcare plans industry, has been capturing investor attention with its remarkable revenue growth and a promising potential upside. Based in Orange,..

Premier, Inc. (PINC) Investor Outlook: Navigating A Challenging Healthcare Landscape with a Strong Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare improvement sector, offers a diverse array of solutions aimed at enhancing provider performance, optimizing supply chains, and fostering value-based care...

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring an 88.57% Upside Potential

GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $2.61 billion, this Stamford,..

Scholar Rock Holding Corp. (SRRK) Stock Analysis: Biotech Innovator with Strong Buy Signals

Scholar Rock Holding Corporation (NASDAQ: SRRK) is a notable player in the biotechnology sector, engaging in pioneering work to develop treatments targeting serious diseases influenced by protein growth factor signaling...

Warby Parker Inc. (WRBY) Stock Analysis: Evaluating a 21% Upside Potential

Warby Parker Inc. (NYSE: WRBY) stands out in the healthcare sector with its innovative approach to eyewear retail. As a prominent player in the medical instruments and supplies industry, the..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 32% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a standout player in the dynamic biotechnology sector, offering a diverse portfolio of licensed biopharmaceutical assets. Based in Jupiter, Florida, Ligand is a significant..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 60% Potential Upside in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) has been catching the attention of investors with its promising 60.07% potential upside, according to recent analyst ratings. Specializing in Medicare Advantage plans across..

Concentra Group Holdings (CON): Analyst Ratings Signal 21% Upside in Healthcare Stock

For investors seeking opportunities within the healthcare sector, Concentra Group Holdings Parent (CON) offers an intriguing proposition. Headquartered in Addison, Texas, Concentra has carved out a significant niche in the..

Crinetics Pharmaceuticals, Inc. (CRNX): Investor Outlook with a 99% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotech firm focused on pioneering treatments for rare endocrine diseases, is capturing the attention of savvy investors with a staggering potential upside of..

Addus HomeCare Corporation (ADUS) Stock Analysis: 23.9% Upside Potential Makes It a Compelling Buy

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, is drawing investor attention with its robust growth trajectory and promising analyst ratings. The company, headquartered in Frisco,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Evaluating a 25% Upside Potential in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline and notable potential for growth. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Potential 75% Upside in the Biotech Sector

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with a market capitalization of $2.93 billion, focusing on developing therapeutics for neurodegenerative and lysosomal storage diseases. Despite its..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking a Potential 33% Upside for Investors

Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers a compelling opportunity for investors seeking growth in the innovative field of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds